$Pfizer(PFE)$ Analysts have downgraded Pfizer due to less demand for Covid vaccines. The big question mark is about their Paxlovid treatment and future earnings expectations from countries. There seems to be no current information for greater future earnings projections. When there is news, the selling price will likely go up. I see the near term as a potential buying opportunity.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Good